# Interest of Whole-body MRI Correlated to Spreading Sequences for Staging Neuroendocrine Tumors

> **NCT02786303** · NA · UNKNOWN · sponsor: **CHU de Reims** · enrollment: 100 (estimated)

## Conditions studied

- Neuroendocrine Tumors With Metastasis

## Interventions

- **DEVICE:** Whole-body diffusion- weighted MRI

## Key facts

- **NCT ID:** NCT02786303
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2016-04
- **Final completion:** 2017-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02786303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02786303, "Interest of Whole-body MRI Correlated to Spreading Sequences for Staging Neuroendocrine Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02786303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*